Bustamante, Pauleen Y.
HRN: 18-12-54 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/08/2022
CEFUROXIME 750MG (VIAL)
07/08/2022
07/15/2022
IV
360mg
Q8h
Uti
Waiting Final Action